Business Wire

NESSUM-ALLIANCE

21.5.2024 10:01:27 CEST | Business Wire | Press release

Share
Connecting the Future with Any Media Communication: NESSUM Alliance's Groundbreaking Technology Incorporated in International Standard IEEE 1901!

In a groundbreaking stride toward advancing communication standards in the digital age, the NESSUM Alliance is proud to announce the release of the IEEE 1901c standard on May 15th. This transformative standard, created from the collaborative efforts of NESSUM's esteemed members, now stands poised to redefine connectivity paradigms worldwide, under the rebranded banner of NESSUM.

With the introduction of IEEE 1901c, formerly known as 'HD-PLC,' NESSUM introduces many new and unparalleled features:

  • Long-Distance Communication: Spanning several kilometers, NESSUM enables a new era of expansive reach.
  • Broadband Communication: Operating in the Mbps class, this standard ensures seamless transmission of data across networks.
  • IP Compatibility: Using standardized Internet Protocol (IP), NESSUM seamlessly integrates with existing infrastructures.
  • Topology-Free Configuration: Facilitating flexible networking, NESSUM overcomes conventional constraints of network configurations.
  • Safety and Security: Prioritizing network and user safety, NESSUM ensures robust and secure communication channels.

Besides high-speed communication on any wire, NESSUM technology also enables the transmission of weak radio signals, facilitating short-range wireless communication applications, including underwater environments. This makes it a truly versatile solution for any media.

The IEEE began the development of the any medium communication standard for IoT applications as IEEE P1901c in May 2022, including the adoption of the Wavelet OFDM method - one of the advanced feature sets of NESSUM's technological advantages compare to other (power line) solutions. After months of effort and refinement, IEEE 1901c attained formal approval in February of this year, marking a monumental leap forward in communication standards.

Mr. Jean-Philippe Faure, Chair of the IEEE 1901WG, lauded the contributions of NESSUM Alliance's expert members, affirming, "This new standard expands the application range of powerline communication to various existing lines and supports low-power radio, opening up new possibilities for high-speed short-range wireless communication."

Agreeing to this sentiment, Mr. Hiroshi Saijo, Head of Business Development & Strategy at Panasonic Holdings Corporation, articulated a shared vision of global proliferation, stating, "We aim to spread this IoT communication standard worldwide as an international standard, not only in products but also in applications."

Mr. Keishi Kajiwara, Director of the Communication Business Division at MegaChips Corporation expressed eager anticipation for market expansion and collaborative endeavors with the new standard, NESSUM's pivotal role in driving innovation.

Mr. Christopher Trabold, CTO and Business Development Leader for Asset Monitoring and Communication at General Electric Vernova, emphasized the burgeoning demand for powerline communication with the digitalization of power infrastructure, signaling a promising trajectory for IEEE 1901c.

IEEE 1901c's transformative capabilities extend to long-distance powerline communication, now covering the several hundred kHz band as NBPLC through innovative resampling. This evolutionary leap finds resonance in diverse sectors, from medium-voltage system control to smart meters, with new applications in Asia and beyond.

Mr. Markus Rindchen, Head of Technology Management at Power Plus Communications AG, pointed out the indispensable role of NESSUM in Germany's Smart Meter Gateway business, underscoring its essential role for the mass roll-out.

Mr. Tomislav Drenski, Marketing Manager at Socionext Europe GmbH is excited to promote the new NESSUM ICs. These advanced ICs offer unique features such as high speed, stable and secure long-distance communication, which surpass other power line solutions available in the market.

With a strong long-term commitment to meet evolving market demands and continuously develop innovation in the IoT landscape, the NESSUM Alliance promotes and supports Any Media communications being inter-operable worldwide. Through a multifaceted approach encompassing webinars, seminars, exhibitions, and extensive promotional activities, the alliance is confident and certain to drive future state-of-the-art solutions with increased compatibility, and lead international standardization efforts.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521360203/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye